Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725790 | SCV000339408 | uncertain significance | not provided | 2016-02-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725790 | SCV000732623 | benign | not provided | 2019-09-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000725790 | SCV002321438 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436110 | SCV002745830 | likely benign | Cardiovascular phenotype | 2020-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |